16.12.2010 • NewsDow ChemicalexpansionThailand

Dow Chemical Plans $67 Million Expansion in Thailand

Dow Chemical plans to invest 2 billion baht ($67 million) to expand its propylene glycol production in Thailand, the Board of Investment (BOI) said on Thursday.

The new plant, to be located at the Asia Industrial Estate in the eastern province of Rayong, would have annual capacity of 150,000 tons, the BOI said in a statement.

Propylene glycol is a raw material for the manufacture of consumer products in the medical and food sectors.

Dow Chemical, which has five propylene glycol plants, has invested about 142.4 billion baht in Thailand, including its own investments and joint ventures with Siam Cement, Thailand's top industrial conglomerate, the statement said.

The BOI issued the statement after a recent visit by Industry Minister Chaiwuth Bannawat to the United States to promote investment in Thailand.

Guardian Industries, a U.S. producer of glass and other car parts, planned to invest 1.5 billion baht to improve equipment at its plant in Saraburi province, the BOI statement said.

Company

The Dow Chemical Company

100 Larkin Center
48674 Midland

Company contact







Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.